Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer

Clinical trial NCT01022541 · COMPLETED

Trial details

NCT number: NCT01022541
Sponsor: Royal Marsden NHS Foundation Trust
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2006-06-01
Primary completion: 2010-12-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.